Black Rock Inc. Janux Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,693,991 shares of JANX stock, worth $71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,693,991

Previous 1,762,101 3.87%

Holding current value

$71 Million

Previous $18.9 Million 237.32%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$7.93 - $49.75 $540,112 - $3.39 Million	-68,110 Reduced 3.87%	1,693,991 $63.8 Million
Q4 2023 Feb 13, 2024	BUY	$5.85 - $11.7 $716,753 - $1.43 Million	122,522 Added 7.47%	1,762,101 $18.9 Million
Q3 2023 Nov 13, 2023	BUY	$9.56 - $14.0 $4.25 Million - $6.23 Million	444,991 Added 37.25%	1,639,579 $16.5 Million
Q2 2023 Aug 11, 2023	BUY	$11.08 - $15.92 $664,168 - $954,292	59,943 Added 5.28%	1,194,588 $14.2 Million
Q1 2023 May 12, 2023	BUY	$11.25 - $22.21 $355,387 - $701,613	31,590 Added 2.86%	1,134,645 $13.7 Million

Q4 2022 Feb 13, 2023	SELL	$11.1 - $18.26 $1.63 Million - $2.69 Million	-147,293 Reduced 11.78%	1,103,055 $14.5 Million
Q3 2022 Nov 14, 2022	BUY	$10.82 - $16.84 $454,375 - $707,178	41,994 Added 3.48%	1,250,348 $16.9 Million
Q2 2022 Aug 12, 2022	BUY	$9.52 - $15.65 $443,946 - $729,806	46,633 Added 4.01%	1,208,354 $14.8 Million
Q1 2022 May 12, 2022	BUY	$13.24 - $20.24 $2.03 Million - $3.11 Million	153,460 Added 15.22%	1,161,721 $16.7 Million
Q4 2021 Feb 10, 2022	BUY	$15.44 - $27.32 $3.19 Million - $5.64 Million	206,483 Added 25.75%	1,008,261 $19.9 Million
Q3 2021 Nov 09, 2021	BUY	$20.7 - $34.69 $14.3 Million - $24 Million	691,831 Added 629.24%	801,778 $17.3 Million
Q2 2021 Aug 11, 2021	BUY	$18.58 - $25.37 $2.04 Million - $2.79 Million	109,947 New	109,947 $2.74 Million

Others Institutions Holding JANX

# of Institutions

123

Shares Held

25.3M

Call Options Held

92K

Put Options Held

161K

View Full List

About Janux Therapeutics, Inc.

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $1.75B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

More about JANX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account